Early Phase centers recognized by the National Cancer Institute (INCa for…

Unique centers recognized by the French National Cancer Institute INCa to foster development of early phases trials in oncology CLIP² Saint-Louis Paris Nord - KILADJIAN Jean-Jacques - APHP - Saint-Louis Hospital CLIP2 CARPEM ACTI MEDIONI Jacques – CLIP2 CARPEM ACTI MEDIONI Jacques – Cochin, Necker and Georges Pompidou Hospitals CARPEM-ACTI is composed of 3 partners sites (HEGP, Cochin & Necker) with a strong expertise in First In Man/Phase 1 clinical trials (breast, gynecology, digestive, urologic, lung, sarcomas, lymphomas & leukemias). The clinical research project is structured into 5 main axes, 1) First-in-Man studies. 2) Immune checkpoint inhibitors. 3) Vectorized internal radiotherapy. 4) Molecularly targeted therapies. 5) Interventional radiology. Director: Dr J. Medioni. Deputy directors: Pr J. Alexandre, Dr L.Frenzel & Pr O. Hermine.